The relationship of blood glucose with cardiovascular disease is mediated over time by traditional risk factors in type 1 diabetes: the DCCT/EDIC study
Open Access
- 16 July 2017
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 60 (10) , 2084-2091
Abstract
Aims/hypothesis Chronic hyperglycaemia, as measured by HbA1c levels, is a major risk factor for atherosclerosis and cardiovascular disease (CVD) in type 1 diabetes. Our aim was to describe the degree to which the effect of HbA1c on the risk of CVD is mediated by its effect on traditional risk factors over time, and how these mediation pathways change over time. Methods The DCCT and its observational follow-up study, the Epidemiology of Diabetes Interventions and Complications (EDIC), followed 1441 participants for a mean of 27 years, with periodic measurement of HbA1c and risk factors over time. We assessed the proportion of the HbA1c effect on risk of CVD that was mediated through its effects on systolic BP (SBP), pulse rate, triacylglycerols and LDL-cholesterol (LDLc) levels, and how the proportion mediated changed over time. Results The association of HbA1c with CVD outcomes was stable over time, while that of traditional risk factors (SBP, pulse rate, triacylglycerols and LDLc) increased. At 10 years of follow-up, the effect of HbA1c on 10 year CVD risk was minimally mediated by SBP (2.7%), increasing to 26% at 20 years. Likewise, from 10 year follow-up to 20 year follow-up, the proportion of HbA1c effect mediated through pulse rate increased from 6.3% to 29.3%, through triacylglycerols from 2.2% to 22.4%, and through LDLc from 9.2% to 30.7%. Conclusions/interpretation As participants age, the predictive association of mean HbA1c on subsequent CVD events is increasingly mediated by its effect on standard risk factors. Thus, management of traditional non-glycaemic CVD risk factors may have increasing benefits in an ageing type 1 diabetes population with longstanding hyperglycaemia. Trial registration: ClinicalTrials.gov NCT00360893 and NCT00360815.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (U01 DK094176)
This publication has 17 references indexed in Scilit:
- Update on Cardiovascular Outcomes at 30 Years of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications StudyDiabetes Care, 2013
- Risk of Cardiovascular Disease and Total Mortality in Adults with Type 1 Diabetes: Scottish Registry Linkage StudyPLOS Medicine, 2012
- Direct and Indirect Effects in a Survival ContextEpidemiology, 2011
- Long-term Renal Outcomes of Patients With Type 1 Diabetes Mellitus and MicroalbuminuriaAn Analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications CohortMicroalbuminuria Outcomes in Type 1 DiabetesArchives of internal medicine (1960), 2011
- General Cardiovascular Risk Profile for Use in Primary CareCirculation, 2008
- The Effect of Intensive Diabetes Treatment on Resting Heart Rate in Type 1 DiabetesDiabetes Care, 2007
- Type 1 Diabetes and Coronary Artery DiseaseDiabetes Care, 2006
- Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 DiabetesNew England Journal of Medicine, 2005
- Survival Model Predictive Accuracy and ROC CurvesBiometrics, 2005
- The Diabetes Control and Complications Trial (DCCT): Design and Methodologic Considerations for the Feasibility PhaseDiabetes, 1986